Market Research Forecasts Autoimmune Disorders Therapeutics Market at $61 Billion by 2017

ROCKVILLE, MD--(Marketwire - May 21, 2012) - MarketResearch.com has announced the addition of the new report "Autoimmune Disorders Therapeutics Market to 2017 -- Launch of Gilenya and Benlysta to Drive the Growth of Multiple Sclerosis and Systemic Lupus Erythematosus Therapeutic Segments" to their collection of Diseases & Conditions market reports. For more information, visit http://www.marketresearch.com/GBI-Research-v3759/Autoimmune-Disorders-Therapeutics-Launch-Gilenya-6927052/